Related Experiment Video
Updated: Jul 15, 2025
09:29
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.2K
Launching Relationship-Oriented Behavioral Services for Youth Opioid Use Disorder: Innovations in Medication
Aaron Hogue1, Molly Bobek1, Nicole Porter1
1Family & Adolescent Clinical Technology & Science, Partnership to End Addiction, New York, USA.
Child & Family Behavior Therapy
|September 28, 2023
Summary
This study introduces three behavioral interventions to improve medication for opioid use disorder (MOUD) adherence and recovery in young adults. These flexible, relationship-focused approaches address barriers and support long-term treatment success.
Area of Science:
- Addiction Medicine
- Behavioral Psychology
- Adolescent Health
Background:
- Opioid use disorder (OUD) significantly impacts transition-age youth (16-25 years).
- Medication for opioid use disorder (MOUD) is effective but faces challenges in youth populations.
- Barriers to MOUD uptake and retention require targeted interventions.
Purpose of the Study:
- To present novel behavioral interventions for enhancing MOUD uptake and retention in transition-age youth.
- To describe three interconnected, flexible interventions: Relational Orientation, Medication Education and Decision-making Support, and Family Leadership and Ownership of Adherence to Treatment.
- To provide case examples demonstrating tailored application for diverse youth profiles.
Main Methods:
- Development of three relationship-oriented behavioral interventions.
- Focus on addressing barriers to MOUD uptake.
- Emphasis on adherence planning and strengthening recovery.
Main Results:
- Interventions are designed to be interconnected and flexibly delivered.
- Modular approach allows for tailoring to individual client needs.
- Case examples illustrate practical application and adaptability.
Conclusions:
- Behavioral interventions can significantly improve MOUD engagement and outcomes in youth.
- Relationship-focused strategies are key to overcoming adherence barriers.
- Flexible, modular interventions offer a promising model for personalized OUD treatment in young adults.
Related Concept Videos
01:28Drug Therapy
60
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
60
01:02Prescription, Nonprescription and Orphan Drugs
756
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
756
01:15Drug Abuse and Addiction: Pharmacological Phenomena
501
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
501
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
01:26Drug Administration and Therapy Phases: Overview
504
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
504
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
326
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
326